Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...
Validated clinical efficacy and scalable manufacturing propel exosomes from research discovery to commercial therapeutics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback